Jan 30, 2024 | Science, Services
Case Study: Reptor Biological vs Technical Replicates Project Summary Next-generation sequencing of B cell populations (Rep-Seq) has become a powerful tool in immunology and antibody discovery. At Abterra Bio we developed Reptor, an integrated Rep-Seq sequencing and...
Jul 14, 2023 | Products, Science
New Service: Alicanto for Antibody Discovery from Human Serum We recently had the pleasure of attending the PEGS Boston Conference. We had the privilege of showcasing our work through a poster presentation, a talk, and an exhibit booth. Among the highlights were...
Jul 13, 2023 | Products, Science
Case Study: Reptor Phage Enrichment Project Summary Phage display is a powerful toolkit for antibody discovery and engineering. In this study, we used phage display to identify Cas9-binding single domain (VHH) antibodies. In addition to traditional colony picking, we...
Oct 4, 2022 | Products, Science, Services
Advantages of High-Throughput Hybridoma Sequencing with NGS Having a diverse collection of leads at the beginning of your antibody development campaign is critical for downstream success. As we know well, the immune response to immunization often focuses on a small...
Aug 30, 2022 | Products, Science, Services
Why Sequence My Antibody Protein? Over the past decade of sequencing thousands of antibodies, we’ve discovered the top reasons to sequence your antibody protein. Top reasons to sequence my antibody 1. To protect my intellectual property through patents...
Jun 28, 2022 | Science, Services
Case Study: Alicanto Discovers High Affinity Rabbit Antibodies to Detect Neurofibromin Researchers at Infixion Bioscience are on a mission to develop new therapeutics for the “orphan disease” neurofibromatosis type 1, which is diagnosed at a rate 1 in 3000 live...